Calcium Carbonate Tablets
DEFINITION
Calcium Carbonate Tablets contain NLT 90.0% and NMT 110.0% of the labeled amount of calcium carbonate (CaCO3). For Tablets labeled for any indication other than, or in addition to, antacid use, the Tablets contain NLT 90.0% and NMT 115.0% of the labeled amount of calcium carbonate.
IDENTIFICATION
• A. Identification TestsGeneral, Calcium 191:
The addition of 6 N acetic acid to the Tablets produces effervescence, and the resulting solution, after being boiled to expel carbon dioxide and neutralized with 6 N ammonium hydroxide, meets the requirements.
ASSAY
• Procedure
Sample solution:
Finely powder NLT 20 Tablets. Transfer a portion of the powder, equivalent to 200 mg of calcium carbonate, to a suitable crucible. Ignite to constant weight. Cool the crucible, add 10 mL of water, and dissolve the residue by adding sufficient 3 N hydrochloric acid, dropwise, to achieve complete solution.
Blank:
150 mL of water and 15 mL of 1 N sodium hydroxide
Titrimetric system
(See Titrimetry 541.)
Mode:
Direct titration
Titrant:
0.05 M edetate disodium VS
Indicator:
300 mg of hydroxy naphthol blue
Endpoint detection:
Visual, change to distinct blue
Analysis:
Transfer the Sample solution completely to a suitable container, and dilute with water to 150 mL. Add 15 mL of 1 N sodium hydroxide and 300 mg of hydroxy naphthol blue. Titrate with the Titrant.
Calculate the percentage of calcium carbonate (CaCO3) in the sample taken:
Result = [(VS VB) × M × F × 100]/W
Acceptance criteria:
90.0%110.0% of the labeled amount of CaCO3. For Tablets labeled for any indication other than, or in addition to, antacid use, 90.0%115.0% of the labeled amount of CaCO3
PERFORMANCE TESTS
• Dissolution 711
[NoteFor Tablets labeled for any indication other than, or in addition to, antacid use. ]
Medium:
0.1 N hydrochloric acid; 900 mL
Apparatus 2:
75 rpm
Time:
30 min
Lanthanium chloride solution:
50 mg/mL of lanthanum chloride in 0.1 N hydrochloric acid
Standard stock solution:
100 µg/mL of calcium in 0.1 N hydrochloric acid
Standard solutions:
Into separate 100-mL volumetric flasks containing 10.0 mL of Lanthanium chloride solution pipet 3-, 4-, 5-, and 6-mL portions of Standard stock solution and dilute each with 0.1 N hydrochloric acid to volume to obtain solutions with calcium concentrations of 3, 4, 5, and 6 µg/mL, respectively.
Sample solution:
Filter a portion of the solution under test. Pipet a volume of the filtrate, estimated to contain 1 mg of calcium, into a 250-mL volumetric flask. Add 25.0 mL of Lanthanium chloride solution, and dilute with 0.1 N hydrochloric acid to volume.
Instrumental conditions
Mode:
Atomic absorption spectrophotometry
Analytical wavelength:
422.8 nm
Lamp:
Calcium hollow-cathode
Flame:
Airacetylene
Blank:
Lanthanium chloride solution and 0.1 N hydrochloric acid (1:9)
Analysis
Samples:
Standard solutions and Sample solution
Concomitantly determine the absorbances of the Standard solutions and the Sample solution against the Blank. Construct a standard curve by plotting absorbances versus calcium concentrations of the Standard solutions, then from it obtain the concentration, CS, in µg/mL of calcium, of the Sample solution.
Calculate the percentage of the labeled amount of calcium carbonate (CaCO3) dissolved:
Result = (Mr/Ar) × (C × D × V/L) × 100
Tolerances:
NLT 75% (Q) of the labeled amount of calcium carbonate (CaCO3) is dissolved.
• Uniformity of Dosage Units 905:
Meet the requirements
SPECIFIC TESTS
• Acid-Neutralizing Capacity 301:
For Tablets labeled for antacid use
Analysis:
Proceed as directed in the chapter.
Acceptance criteria:
NLT 5 mEq of acid is consumed by the minimum single dose recommended in the labeling, and NLT the number of mEq calculated as follows:
Result = (C × ANC) × F
ADDITIONAL REQUIREMENTS
• Packaging and Storage:
Preserve in well-closed containers.
• Labeling:
Label it to indicate whether it is for use as an antacid, or as a dietary supplement, or both.
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
USP35NF30 Page 2445
Pharmacopeial Forum: Volume No. 28(5) Page 1392
|